Literature DB >> 2769278

Risk factors for the syndrome of ventricular enlargement with gait apraxia (idiopathic normal pressure hydrocephalus): a case-control study.

M Casmiro1, R D'Alessandro, F M Cacciatore, R Daidone, F Calbucci, E Lugaresi.   

Abstract

A case-control study was performed to verify the association between the risk factors for cerebrovascular disease and the syndrome of ventricular enlargement with gait apraxia (VEGAS). This syndrome was defined on the basis of clinical and CT criteria alone; however, it may be representative of patients with idiopathic normal pressure hydrocephalus in whom gait disturbance is the initial symptom. Seventeen patients were matched for age and sex with one hospitalised and two general population controls. Among the risk factors considered we found a significant statistical association between VEGAS and hypertension (odds ratio = 3.14; p = 0.032), ischaemic heart disease (odds ratio = 4.20; p = 0.013), ECG ischaemic changes (odds ratio = 3.67; p = 0.029), low HDL-cholesterol levels (odds ratio = 3.75; p = 0.028) and diabetes (odds ratio = 6.00; p = 0.018). Our findings indicate that risk factors for cerebrovascular disease may play a role in the development of VEGAS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2769278      PMCID: PMC1031931          DOI: 10.1136/jnnp.52.7.847

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

1.  RISA-VENTRICULOGRAPHY AND RISA-CISTERNOGRAPHY.

Authors:  G DICHIRO; P M REAMES; W B MATTHEWS
Journal:  Neurology       Date:  1964-03       Impact factor: 9.910

2.  SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME.

Authors:  R D ADAMS; C M FISHER; S HAKIM; R G OJEMANN; W H SWEET
Journal:  N Engl J Med       Date:  1965-07-15       Impact factor: 91.245

3.  Cerebrospinal fluid absorption deficit in normal pressure hydrocephalus.

Authors:  A V Lorenzo; M J Bresnan; C F Barlow
Journal:  Arch Neurol       Date:  1974-05

4.  Occult normal pressure hydrocephalus manifested by parkinsonism-dementia complex.

Authors:  G W Sypert; H Leffman; G A Ojemann
Journal:  Neurology       Date:  1973-03       Impact factor: 9.910

5.  Normal pressure hydrocephalus: a histologic study.

Authors:  F H DeLand; A E James; D J Ladd; B W Konigsmark
Journal:  Am J Clin Pathol       Date:  1972-07       Impact factor: 2.493

6.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

7.  A simple constant-infusion manometric test for measurement of CSF absorption. I. Rationale and method.

Authors:  R Katzman; F Hussey
Journal:  Neurology       Date:  1970-06       Impact factor: 9.910

8.  A case of normal pressure hydrocephalus presenting as levodopa responsive parkinsonism.

Authors:  C G Clough
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

9.  The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics.

Authors:  S Hakim; R D Adams
Journal:  J Neurol Sci       Date:  1965 Jul-Aug       Impact factor: 3.181

10.  Normal-pressure hydrocephalus. Onset of gait abnormality before dementia predicts good surgical outcome.

Authors:  N R Graff-Radford; J C Godersky
Journal:  Arch Neurol       Date:  1986-09
View more
  12 in total

1.  Normal pressure hydrocephalus: new concepts on etiology and diagnosis.

Authors:  W G Bradley
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

Review 2.  The differential diagnosis and treatment of normal-pressure hydrocephalus.

Authors:  Michael Kiefer; Andreas Unterberg
Journal:  Dtsch Arztebl Int       Date:  2012-01-09       Impact factor: 5.594

3.  Vascular risk factors in INPH: A prospective case-control study (the INPH-CRasH study).

Authors:  Hanna Israelsson; Bo Carlberg; Carsten Wikkelsö; Katarina Laurell; Babar Kahlon; Göran Leijon; Anders Eklund; Jan Malm
Journal:  Neurology       Date:  2017-01-06       Impact factor: 9.910

Review 4.  Three decades of normal pressure hydrocephalus: are we wiser now?

Authors:  J A Vanneste
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

5.  Increased intracranial volume: a clue to the etiology of idiopathic normal-pressure hydrocephalus?

Authors:  William G Bradley; Francis G Safar; Claudia Furtado; Claudia Hurtado; Justin Ord; John F Alksne
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

6.  Vascular factors in suspected normal pressure hydrocephalus: A population-based study.

Authors:  Daniel Jaraj; Simon Agerskov; Katrin Rabiei; Thomas Marlow; Christer Jensen; Xinxin Guo; Silke Kern; Carsten Wikkelsø; Ingmar Skoog
Journal:  Neurology       Date:  2016-01-15       Impact factor: 9.910

7.  Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH.

Authors:  Jan Malm; Neill R Graff-Radford; Masatsune Ishikawa; Bo Kristensen; Ville Leinonen; Etsuro Mori; Brian K Owler; Mats Tullberg; Michael A Williams; Norman R Relkin
Journal:  Fluids Barriers CNS       Date:  2013-06-10

8.  Cardiac output in idiopathic normal pressure hydrocephalus: association with arterial blood pressure and intracranial pressure wave amplitudes and outcome of shunt surgery.

Authors:  Per K Eide
Journal:  Fluids Barriers CNS       Date:  2011-02-04

9.  Increased prevalence of cardiovascular disease in idiopathic normal pressure hydrocephalus patients compared to a population-based cohort from the HUNT3 survey.

Authors:  Per Kristian Eide; Are Hugo Pripp
Journal:  Fluids Barriers CNS       Date:  2014-08-19

10.  Cardiovascular risk factors in Chiari malformation and idiopathic intracranial hypertension.

Authors:  Radek Frič; Are Hugo Pripp; Per Kristian Eide
Journal:  Brain Behav       Date:  2017-03-28       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.